GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75N93019C00062WASHINGTON UNIVERSITY, THE

Overview

Award facts

Net obligations
$11.67M
$11,665,407of $11.67M potential value
Outlays (paid to date)
$8.87M
$8.87M paid of $11.67M obligated$8,873,013
Period of performance
Sep 16, 2019 to Aug 14, 2026
Ended
Modifications
24
Latest action Feb 11, 2025
Contract type
Definitive contract
PIID 75N93019C00062

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

B CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION

Dates and value

Award date
Signed on Sep 13, 2019
Potential end of performance
Aug 13, 2026
Current value
$11,665,407Base and exercised options
Potential value (if all options are exercised)
$11,665,407

Obligations by fiscal year of action

  • FY2025: -$45,413 (de-obligation)
  • FY2024: -$6,734 (de-obligation)
  • FY2023: $1,671,692
  • FY2022: $3,240,667
  • FY2021: $1,722,037
  • FY2020: $3,492,590
  • FY2019: $1,590,568

Total across 7 fiscal years: $11,665,407

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Feb 11, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationSAINT LOUIS, MO
UEIL6NFUM28LQM5
CAGE code2B003
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt

Business types and certifications

Educational institutionTax-exempt corporation

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Saint Louis, Saint Louis City, Missouri 63110-1093
Congressional district (place of performance)
MO-01As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
8

Solicitation and notices

Solicitation ID
BAANIAIDDAITNIHAI20180(as reported)
Solicitation date
May 22, 2018

Contract details

Subcontracting plan
Individual subcontract planF
Major program
Igf::ot::igf b cell epitope discovery and mechanisms of antibody protection
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 13, 2019Base obligation at award: $1,590,568
Latest action
Feb 11, 2025 — Other administrative actionModification P00024; obligation change -$45,413; administrative: no change in scope or value
Latest substantive action
Aug 16, 2023 — Option exercisedModification P00020; obligation change +$1,671,692
Actions by type
  • Base award1
  • Other administrative action18
  • Option exercised4
  • Supplemental agreement (within scope)2
25 actions recorded, Sep 13, 2019 to Feb 11, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$45,413
Latest action: change in base and all options
-$45,413

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
25

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2019/2019-0885-000
  • 075-2020/2020-0885-000
  • 075-2020/2024-0885-000
  • 075-2021/2021-0885-000
  • 075-2022/2022-0885-000
  • 075-2023/2023-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • L: Emergency P.L. 116-123
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
COVID-19 supplemental outlays
$1,809,888